SLC1A2 and epilepsy: The fact that one of the worsening effects of epilepsy is due to a decrease in GLT-1 expression and thus increasing the extracellular glutamate levels, give rise to the hypothesis that astrocytic glutamate uptake has an important role in the progression of epileptogenesis and it could be a valuable target in anti-epileptic therapies.